{"component": "definition", "props": {"groups": [{"snippet": "shall have the meaning set forth in Section 4.3(c) hereof.", "snippet_links": [], "size": 7, "samples": [{"hash": "70fYgjjfIvJ", "uri": "/contracts/70fYgjjfIvJ#significant-deviation", "label": "Exclusive Agency and Marketing Agreement (Scotts Miracle-Gro Co)", "score": 21.0, "published": true}, {"hash": "gT3C2TsBDcx", "uri": "/contracts/gT3C2TsBDcx#significant-deviation", "label": "Exclusive Agency and Marketing Agreement (Scotts Company)", "score": 18.0, "published": true}, {"hash": "8O8EL0aJfN4", "uri": "/contracts/8O8EL0aJfN4#significant-deviation", "label": "Exclusive Agency and Marketing Agreement (Scotts Company)", "score": 18.0, "published": true}], "hash": "67b278e0ce5dedd20f5d56c0244ab706", "id": 1}, {"snippet": "means any deviation: (i) resulting in an immediate or probable wide-ranging impact on GMP products, processes or systems in any facility where activities are conducted pursuant to this Agreement, (ii) which could result in significant Product safety or efficacy risks (e.g., sterility failure or data integrity issues), (iii) which would require notification to a regulatory authority, or (iv) which would otherwise be considered by reasonable quality assurance professionals to be significant.", "snippet_links": [{"key": "pursuant-to-this-agreement", "type": "clause", "offset": [168, 194]}, {"key": "product-safety", "type": "clause", "offset": [235, 249]}, {"key": "data-integrity", "type": "definition", "offset": [296, 310]}, {"key": "notification-to", "type": "clause", "offset": [346, 361]}, {"key": "regulatory-authority", "type": "definition", "offset": [364, 384]}, {"key": "quality-assurance", "type": "clause", "offset": [444, 461]}], "size": 5, "samples": [{"hash": "iEoKSG4ou38", "uri": "/contracts/iEoKSG4ou38#significant-deviation", "label": "Commercial Manufacturing Agreement", "score": 31.340862423, "published": true}, {"hash": "kNEBGumRxtb", "uri": "/contracts/kNEBGumRxtb#significant-deviation", "label": "Commercial Manufacturing Agreement (Santarus Inc)", "score": 23.173853525, "published": true}, {"hash": "fZRFD7GfE3y", "uri": "/contracts/fZRFD7GfE3y#significant-deviation", "label": "Technology Transfer and Commercial Manufacturing Agreement (Depomed Inc)", "score": 21.0, "published": true}], "hash": "fa45de8ba4b53006d58d753b26ab6d66", "id": 2}, {"snippet": "means an omission, alteration or relocation of an erosion or", "snippet_links": [], "size": 3, "samples": [{"hash": "kit27J7r9Kw", "uri": "https://www.oah.nc.gov/media/10227/download", "label": "www.oah.nc.gov", "score": 9.9965776865, "published": false}, {"hash": "gZgfp7mj2Tg", "uri": "https://files.nc.gov/ncoah/documents/Rules/RRC/02202020-Follow-up-Tab-H-Sedimentation-Control-Commission.pdf", "label": "files.nc.gov", "score": 9.9965776865, "published": false}, {"hash": "4pykOB6zgFb", "uri": "https://files.nc.gov/ncoah/documents/Rules/RRC/03192020-Follow-up-Tab-H-Sedimentation-Control-Commission.pdf", "label": "files.nc.gov", "score": 6.9965776865, "published": false}], "hash": "8b79b53ecc3dc354a16453adebf6e124", "id": 3}, {"snippet": "has the meaning set forth in Attachment B of this QUALITY AGREEMENT.", "snippet_links": [{"key": "b-of", "type": "definition", "offset": [40, 44]}, {"key": "quality-agreement", "type": "clause", "offset": [50, 67]}], "size": 3, "samples": [{"hash": "U57I9nXZPu", "uri": "/contracts/U57I9nXZPu#significant-deviation", "label": "License, Manufacturing and Supply Agreement (Regado Biosciences Inc)", "score": 24.3237508556, "published": true}, {"hash": "hYrjLt4XRiK", "uri": "/contracts/hYrjLt4XRiK#significant-deviation", "label": "License, Manufacturing and Supply Agreement (Regado Biosciences Inc)", "score": 24.2717316906, "published": true}, {"hash": "67fRswZ7iLi", "uri": "/contracts/67fRswZ7iLi#significant-deviation", "label": "License, Manufacturing and Supply Agreement (Adnexus Therapeutics, Inc.)", "score": 21.0, "published": true}], "hash": "8de68f6bf6ab4a3ab435859a7c834bd9", "id": 4}, {"snippet": "means a material variance from the Project Proposal, in so far as the contribution of the Subgrantee is concerned, which might affect the objectives of the Project or the adequate use of the Subgrant, regardless of the cause, e.g. changes in outcome and/or output level, changes to the respective indicators or to crucial activities.", "snippet_links": [{"key": "material-variance", "type": "definition", "offset": [8, 25]}, {"key": "project-proposal", "type": "definition", "offset": [35, 51]}, {"key": "contribution-of-the", "type": "clause", "offset": [70, 89]}, {"key": "objectives-of-the-project", "type": "clause", "offset": [138, 163]}, {"key": "changes-in", "type": "definition", "offset": [231, 241]}, {"key": "changes-to-the", "type": "definition", "offset": [271, 285]}], "size": 3, "samples": [{"hash": "hbzkeOrjfd4", "uri": "/contracts/hbzkeOrjfd4#significant-deviation", "label": "Subgrant Agreement", "score": 34.4347589852, "published": true}, {"hash": "7VL1Ydr6nqu", "uri": "/contracts/7VL1Ydr6nqu#significant-deviation", "label": "Subgrant Agreement", "score": 25.1122518823, "published": true}, {"hash": "e1UWsc2PmrZ", "uri": "/contracts/e1UWsc2PmrZ#significant-deviation", "label": "Subgrant Agreement", "score": 24.6919917864, "published": true}], "hash": "757b41ea8873b4123bed46dd171593b8", "id": 5}, {"snippet": "means any material non-conformity from established requirements as provided in the applicable product registration, applicable validation and/or qualification documents as well as applicable Batch production records and associated procedures, methods and Specifications.", "snippet_links": [{"key": "material-non", "type": "clause", "offset": [10, 22]}, {"key": "established-requirements", "type": "definition", "offset": [39, 63]}, {"key": "product-registration", "type": "definition", "offset": [94, 114]}, {"key": "qualification-documents", "type": "definition", "offset": [145, 168]}, {"key": "batch-production-records", "type": "definition", "offset": [191, 215]}, {"key": "associated-procedures", "type": "definition", "offset": [220, 241]}], "size": 2, "samples": [{"hash": "euKgN5VNTYD", "uri": "/contracts/euKgN5VNTYD#significant-deviation", "label": "Restructuring Agreement (Aradigm Corp)", "score": 21.0, "published": true}, {"hash": "dRO61pmBitF", "uri": "/contracts/dRO61pmBitF#significant-deviation", "label": "Restructuring Agreement (Aradigm Corp)", "score": 21.0, "published": true}], "hash": "f4a5db773361214e02fa745446b3d527", "id": 6}, {"snippet": "means:\n(i) any specification that either falls outside the Approved Package or that cannot be defined because the Approved Package lacks the required information, and whose extrapolation cannot be made, in a straightforward fashion, by means of Foreground or Background. Significant Deviation consists, among others, in : \u2022 [***] \u2022 Changes in Propanol specification \u2022 Changes in safety philosophy Significant Deviation does not include minor changes that are linked to (a) overall performance optimization as a result of the integration of the PFT in existing facilities, (b) lay-out or (c) plot plan considerations.\n(ii) any and all deviation from HSE matters covered by the Approved Package;\n(iii) any and all freedom to operate matters not identified pursuant to Paragraphs 9.1 and 9.2.", "snippet_links": [{"key": "required-information", "type": "definition", "offset": [141, 161]}, {"key": "changes-in", "type": "definition", "offset": [332, 342]}, {"key": "minor-changes", "type": "clause", "offset": [436, 449]}, {"key": "performance-optimization", "type": "clause", "offset": [481, 505]}, {"key": "existing-facilities", "type": "clause", "offset": [551, 570]}, {"key": "plot-plan", "type": "clause", "offset": [591, 600]}, {"key": "matters-covered-by", "type": "clause", "offset": [653, 671]}, {"key": "freedom-to-operate", "type": "definition", "offset": [712, 730]}, {"key": "pursuant-to", "type": "definition", "offset": [754, 765]}], "size": 2, "samples": [{"hash": "hvazsrcglCw", "uri": "/contracts/hvazsrcglCw#significant-deviation", "label": "Joint Development Agreement", "score": 31.340862423, "published": true}, {"hash": "1pIAFL5Yg8o", "uri": "/contracts/1pIAFL5Yg8o#significant-deviation", "label": "Joint Development Agreement (Coskata, Inc.)", "score": 23.0698151951, "published": true}], "hash": "24ae529e0486a8943f93f04823573128", "id": 7}, {"snippet": "has the meaning set forth in the Contract Manufacturing Agreement.", "snippet_links": [{"key": "contract-manufacturing-agreement", "type": "definition", "offset": [33, 65]}], "size": 2, "samples": [{"hash": "euKgN5VNTYD", "uri": "/contracts/euKgN5VNTYD#significant-deviation", "label": "Restructuring Agreement (Aradigm Corp)", "score": 21.0, "published": true}, {"hash": "dRO61pmBitF", "uri": "/contracts/dRO61pmBitF#significant-deviation", "label": "Restructuring Agreement (Aradigm Corp)", "score": 21.0, "published": true}], "hash": "9ddd774eba208f99540e3893dfb79672", "id": 8}, {"snippet": "means:\n(i) any specification that either falls outside the Approved Package or that cannot be defined because the Approved Package lacks the required information, and whose extrapolation cannot be made, in a straightforward fashion, by means of Foreground or Background. Significant Deviation consists, among others, in : \u2022 Changes in microorganism \u2022 Changes in nutrient agent(s) that changes the microorganism performance by at least [***]% \u2022 Change in reactor concept and/or technology \u2022 Change in volumetric productivity of the reactor by at least [***]% \u2022 Changes in distillation technology (packing vs trays, operating conditions that require other levels of utilities, etc) \u2022 Changes in Propanol specification \u2022 Changes in safety philosophy Significant Deviation does not include minor changes that are linked to (a) overall performance optimization as a result of the integration of the PFT in existing facilities, (b) lay-out or (c) plot plan considerations.\n(ii) any and all deviation from HSE matters covered by the Approved Package; [***] Indicates that text has been omitted which is the subject of a confidential treatment request. The text has been separately filed with the Securities and Exchange Commission.\n(iii) any and all freedom to operate matters not identified pursuant to Paragraphs 9.1 and 9.2.", "snippet_links": [{"key": "required-information", "type": "definition", "offset": [141, 161]}, {"key": "changes-in", "type": "definition", "offset": [324, 334]}, {"key": "performance-by", "type": "definition", "offset": [411, 425]}, {"key": "change-in", "type": "definition", "offset": [444, 453]}, {"key": "operating-conditions", "type": "definition", "offset": [614, 634]}, {"key": "minor-changes", "type": "clause", "offset": [786, 799]}, {"key": "performance-optimization", "type": "clause", "offset": [831, 855]}, {"key": "existing-facilities", "type": "clause", "offset": [901, 920]}, {"key": "plot-plan", "type": "clause", "offset": [941, 950]}, {"key": "matters-covered-by", "type": "clause", "offset": [1003, 1021]}, {"key": "subject-of", "type": "clause", "offset": [1100, 1110]}, {"key": "confidential-treatment-request", "type": "definition", "offset": [1113, 1143]}, {"key": "the-securities-and-exchange-commission", "type": "clause", "offset": [1185, 1223]}, {"key": "freedom-to-operate", "type": "definition", "offset": [1243, 1261]}, {"key": "pursuant-to", "type": "definition", "offset": [1285, 1296]}], "size": 1, "samples": [{"hash": "D377RAwT8e", "uri": "/contracts/D377RAwT8e#significant-deviation", "label": "Joint Development Agreement (Coskata, Inc.)", "score": 23.2368240931, "published": true}], "hash": "ba72c7ffd0a115d49494ff50a139ef0a", "id": 9}, {"snippet": "and \"material impact\" shall mean a material variance from the Bank's strategic plan submitted pursuant to this Agreement, as the term \"significant deviation\" is further described in PPM 5400-9, Appendix B.", "snippet_links": [{"key": "material-impact", "type": "definition", "offset": [5, 20]}, {"key": "material-variance", "type": "definition", "offset": [35, 52]}, {"key": "the-bank", "type": "clause", "offset": [58, 66]}, {"key": "strategic-plan", "type": "definition", "offset": [69, 83]}, {"key": "pursuant-to-this-agreement", "type": "clause", "offset": [94, 120]}, {"key": "the-term", "type": "definition", "offset": [125, 133]}], "size": 1, "samples": [{"hash": "hjkD35nh2GX", "uri": "/contracts/hjkD35nh2GX#significant-deviation", "label": "Compliance Agreement (Metris Companies Inc)", "score": 18.0, "published": true}], "hash": "459ec0255aa4d59cda4766f393bcb400", "id": 10}], "next_curs": "CmISXGoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj4LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIec2lnbmlmaWNhbnQtZGV2aWF0aW9uIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "shall have the meaning set forth in Section 4.3(c) hereof.", "size": 30, "title": "Significant Deviation", "id": "significant-deviation", "examples": ["Any Expense which shall exceed its prescribed Budget shall solely be the responsibility of the party incurring it unless such expense is required to implement an approved <strong>Significant Deviation</strong> from the Annual Business Plan or is necessary to support sales orders above budgeted sales pursuant to sales programs contemplated by the Annual Business Plan.", "AstraZeneca hereby agrees and acknowledges that, upon any delivery of osimertinib by or on behalf of AstraZeneca or its Affiliate to \u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587\u2587 or its Affiliate, such osimertinib will not have a <strong>Significant Deviation</strong> (as defined in the Supply Agreement) or fail to meet Specification (as defined in the Supply Agreement).", "In the event of a dispute regarding whether any Product meets the Specifications or otherwise has a <strong>Significant Deviation</strong>, Perrigo shall submit a sample of such Product to a mutually acceptable independent laboratory for testing and the test results obtained by such laboratory shall be final and controlling.", "Supplier will notify Perrigo within two (2) business days of learning and/or receiving notice, whether before or after delivery of the affected Product to Perrigo, that any Product contains a <strong>Significant Deviation</strong>, foreign material, contaminant, defect or latent defect, Supplier will thoroughly investigate and document all such events.", "In the event the test results indicate that Product in question does meet the Specifications and does not have a <strong>Significant Deviation</strong>, Perrigo shall pay all additional shipping and transportation costs for such Product.", "Perrigo reserves the right to (a) require Supplier to make adjustments to the composition and/or processes that are required to meet FDA standards or requirements; (b) review the validation protocols prior to Supplier\u2019s processing Product; (c) review validation data and reports prior to delivery of Product to Perrigo; and (d) request additional or more in-depth investigations by Supplier of any <strong>Significant Deviation</strong>.", "If Perrigo has a reasonable belief that any Product it receives has a <strong>Significant Deviation</strong>, Perrigo shall promptly notify Supplier after such discovery, and Supplier shall use best efforts to initiate a full investigation within ten (10) business days of being informed of the alleged <strong>Significant Deviation</strong> by Perrigo and shall complete such investigation within thirty (30) days.", "In the event the test results indicate that Product in question fails to meet the Specifications, or otherwise has a <strong>Significant Deviation</strong>, Supplier shall replace such Product, at no additional cost to Perrigo, as soon as reasonably possible, but in no event later than twenty (20) business days after receipt of such results.", "<strong>Significant Deviation</strong> \u2013 A departure from an approved instruction, a standard operation, or a predefined critical parameter, or an unanticipated event that could have an adverse impact, respectively, on the final quality, stability, and/or physical characteristics of the Product."], "related": [["significant-change", "Significant change", "Significant change"], ["significant-deficiency", "Significant deficiency", "Significant deficiency"], ["material-deviation", "Material Deviation", "Material Deviation"], ["significant-assets", "Significant Assets", "Significant Assets"], ["significant-impact", "Significant impact", "Significant impact"]], "related_snippets": [], "updated": "2025-07-07T00:16:39+00:00"}, "json": true, "cursor": ""}}